INEGY 10 MG/10 MG TABLETS

Land: Israel

Språk: engelsk

Kilde: Ministry of Health

Aktiv ingrediens:

EZETIMIBE 10 MG; SIMVASTATIN 10 MG

Tilgjengelig fra:

MERCK SHARP & DOHME ISRAEL LTD

ATC-kode:

C10AA01

Legemiddelform:

TABLETS

Administreringsrute:

PER OS

Produsert av:

MERCK SHARP & DOHME (ITALIA) S.P.A.

Terapeutisk gruppe:

SIMVASTATIN

Indikasjoner:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH.Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Autorisasjon dato:

2012-04-01